Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05711199Phase 1Completed
Phase 1, randomised, open-label trial of nitroglycerin in obesity (2 arms), sponsored by University Hospital Basel. Primary endpoints: Brown Adipose Tissue Standardized Uptake Value mean at 14 days and Brown Adipose Tissue Standardized Uptake Value max at 14 days. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05711199.